WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2025 Issue has been successfully launched on 1 NOVEMBER 2025.

Abstract

“NUTRACEUTICAL VALUE AND ANTIDIABETIC EFFICACY OF MICROGREENS IN TYPE 2 DIABETES MELLITUS”

Keerthi*, J. Archana

ABSTRACT

Type 2 diabetes mellitus (T2DM) remains one of the most prevalent chronic metabolic disorders globally, characterized by insulin resistance, hyperglycemia, and oxidative stress-induced cellular dysfunction. Dietary interventions that incorporate functional foods rich in antioxidants and bioactive compounds have gained increasing attention as complementary strategies for managing diabetes. Microgreens, rich in polyphenols, flavonoids, minerals, and dietary fibers, exhibit superior nutritional and therapeutic potential compared to their mature plant forms. This review systematically explores the preclinical evidence supporting the therapeutic efficacy of Microgreens extract in T2DM management. A comprehensive literature survey was conducted using experimental studies on diabetic rat models induced by streptozotocin (STZ) or high-fat diets. The compiled results demonstrated that microgreen extracts significantly reduced fasting blood glucose levels, improved glucose tolerance, enhanced insulin sensitivity, normalized lipid profiles, and elevated antioxidant enzyme activity (SOD, GSH, and catalase). Histopathological findings further revealed preserved pancreatic islet morphology and ameliorated hepatic and renal damage in treated animals. The mechanisms of action were attributed to the inhibition of carbohydrate-digesting enzymes (α-amylase and α-glucosidase), attenuation of oxidative stress, and modulation of insulin-signaling pathways (IRS-1 and GLUT2 upregulation). The discussion emphasizes multifaceted benefits as a functional food supplement that provides a sustainable, low-cost, and nutritionally rich approach to diabetes management. Although existing findings are promising, human clinical trials are warranted to validate efficacy, optimize dosage, and ensure safety. This review concludes that microgreens represents a potent nutraceutical with substantial potential to serve as an adjunct to conventional antidiabetic therapy and to promote holistic metabolic health.

Keywords: Microgreens, type 2 diabetes mellitus, antioxidants, insulin sensitivity.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More